Compare Bajaj Finserv Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹500
₹500
Expense Ratio
2.39
1.93
NAV
₹9.37
₹428.69
Fund Started
06 Dec 2024
04 Jun 1999
Fund Size
₹307.34 Cr
₹3822.73 Cr
Exit Load
1% for redemption within 3 Months
Exit load of 0.50% if redeemed within 15 days
1 Year
6.35%
8.54%
3 Year
-
25.98%
5 Year
-
17.17%
Equity
95.11%
98.53%
Cash
4.87%
1.39%
Top 10 Holdings
Divi's Laboratories Ltd. | 8.90% |
Sun Pharmaceutical Industries Ltd. | 7.90% |
Apollo Hospitals Enterprise Ltd. | 6.20% |
Aurobindo Pharma Ltd. | 6.01% |
Piramal Pharma Ltd. | 4.00% |
Emcure Pharmaceuticals Ltd. | 3.91% |
Cipla Ltd. | 3.72% |
Neuland Laboratories Ltd. | 3.60% |
Fortis Healthcare Ltd. | 3.33% |
Rubicon Research Ltd. | 3.33% |
Sun Pharmaceutical Industries Ltd. | 10.02% |
Divi's Laboratories Ltd. | 6.96% |
Apollo Hospitals Enterprise Ltd. | 5.46% |
Max Healthcare Institute Ltd. | 5.01% |
Lupin Ltd. | 4.73% |
Acutaas Chemicals Ltd. | 4.50% |
Torrent Pharmaceuticals Ltd. | 4.14% |
Aether Industries Ltd. | 3.67% |
Biocon Ltd. | 3.60% |
Aster DM Healthcare Ltd. | 3.47% |
Name
-
-
Start Date
-
-
Description
The Scheme seeks to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
06 Dec 2024
04 Jun 1999
